Success Stories: NAILG Secured NIW Approval for Postdoc Research Associate in Medicinal Chemistry

Client’s Testimonial:

“Thank you for your continued support throughout the process.”

On July 16^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoc Research Associate in the Field of Medicinal Chemistry (Approval Notice).

General Field: Medicinal Chemistry

Position at the Time of Case Filing: Postdoc Research Associate

Country of Origin: India

State of Residence at the Time of Filing: Missouri

Approval Notice Date: July 16^th, 2025

Processing Time: 3 months, 29 days (Premium Processing Requested)

Case Summary:

Background and Research Impact

NAILG is proud to share the approval of an EB-2 National Interest Waiver (NIW) petition for a researcher in medicinal chemistry whose work focuses on the synthesis and development of small molecules targeting parasitic diseases, particularly cryptosporidiosis and toxoplasmosis. These infections, which disproportionately affect immunocompromised individuals, continue to pose serious health threats worldwide.

The researcher’s proposed endeavor centers on identifying inhibitors that disrupt critical parasitic biological pathways, offering a path to novel and urgently needed treatments. This line of investigation contributes significantly to improving recovery and care outcomes for hundreds of thousands of affected individuals.

Evidence of National Importance

The importance of this work is underscored by funding support from India’s Council of Scientific and Industrial Research. The therapeutic implications of the research are far-reaching, advancing drug discovery for diseases that lack effective treatments and bolstering public health strategies both in the United States and internationally.

NAILG successfully presented this case as one of national interest by demonstrating how the proposed endeavor addresses critical medical challenges and has substantial implications for global health.

Achievements Supporting the Petition

To strengthen the petition, NAILG highlighted several key professional accomplishments:

11 peer-reviewed journal articles, including 5 first-authored
A total of 175 citations, reflecting strong recognition in the scientific community
At least 11 peer reviews completed for academic journals

In addition, an expert evaluator described the researcher’s influence in the following terms:

“In sum, [client]’s skill set is irreplaceable, given its immense benefits to global health, the advancement of neurodegenerative disease treatments, and the biomedical industry. Her research drives transformative progress in drug discovery, accelerates the development of more effective therapies, and enables sustainable, cost-efficient treatment options.”

Outcome

NAILG is proud to have secured NIW approval for this accomplished scientist. Our team carefully evaluated her research contributions, crafted a tailored legal strategy to highlight the national significance of her work, and assembled compelling evidence that satisfied the regulatory requirements. By aligning the scientific merits of her case with the legal standards for a National Interest Waiver, we ensured a persuasive and successful petition. This case reflects NAILG’s commitment to guiding exceptional researchers through complex immigration processes and advancing innovation that benefits public health in the United States.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.